Table 2

Change in characteristics with AET or SED

AETSED
N1213
ΔBMI (kg/m2)−0.5 ± 0.41.1 ± 0.2*
ΔWeight (kg)−1.4 ± 1.03.1 ± 0.8*
ΔFat mass (kg)−1.4 ± 0.72.4 ± 0.7*
ΔFFM (kg)0.4 ± 0.61.1 ± 0.7
ΔFasting plasma glucose (mg/dL)−5.3 ± 2.62.6 ± 2.9^
ΔFasting plasma insulin (μU/mL)−1.4 ± 0.51.0 ± 1.4
ΔFasting plasma C-peptide (nmol/L)−0.09 ± 0.03*0.03 ± 0.03
ΔHOMA−0.6 ± 0.20.3 ± 0.4^
ΔProgesterone (ng/mL)−0.3 ± 0.40.3 ± 1.0
ΔEstradiol (pg/mL)−8.6 ± 7.212.4 ± 10.2
  • No characteristics were different between groups at baseline.

  • *P < 0.05 vs. before intervention (PRE); ^P ≤ 0.06, interaction.